Antibodies after mild covid-19 last for at least a year and also bind the new Delta variant


The COMMUNITY study, which examines long-term immunity after covid-19, has now followed participants for one year and sees that the vast majority still have high levels of antibodies one year after infection. It has been investigated whether the antibodies bind both to the original virus and to a number of new variants, including Alpha (formerly called B 1.117) and Delta, which are currently spreading in Sweden and Europe. The results suggest continued good protection one year after natural infection.

In the spring of 2020, samples were collected from more than 2,000 employees at Danderyd Hospital, where about 19 percent were shown to have antibodies to SARS-CoV-2. Samples were also collected from more than 100 inpatient covid-19 patients. Now a year has passed and the 12-month follow-up has been completed.

The study took a closer look at a group of study participants who fell ill in the spring of 2020 and who have not yet been vaccinated. In this group, it has been possible to study immunity after natural infection over a period of one year. The results show that over 80 percent of those who had mild symptoms in the spring of 2020 still, a year later, have measurable antibody levels. Corresponding analyzes have also been performed in the group of patients who were hospitalized for covid-19, and all have continued measurable antibody levels one year after the infection.

The researchers have also looked at the ability of antibodies to bind the new virus variants, and found that they also bind the Alpha and Delta variants, which now account for the majority of the spread in Sweden and Europe.

No new locally transmitted Covid-19 cases in S’pore for the first time since April 25


There were no new locally transmitted coronavirus cases in Singapore as at Saturday noon (July 10).

It was the first time since April 25 that no new locally transmitted case was reported here.

The six new confirmed cases reported on Saturday were imported, taking Singapore’s total to 62,684, said the Ministry of Health (MOH).

Hungary Has First Day Without Covid Deaths After 10 Months


Hungary, which has suffered the second-highest Covid-related deaths per capita since the pandemic’s outbreak, reported no daily virus-related fatalities for the first time since early September, according to data published on Thursday.

The government plans to scrap most remaining virus curbs this week when 5.5 million people, or about 56% of the population, will have received at least one dose of a Covid-19 vaccine. The improvement in Hungary contrasts with some other countries in Europe and elsewhere that are experiencing fresh outbreaks connected to the delta variant.

The easing of curbs in Hungary will extend to masks, which will no longer be mandatory indoors, including on public transportation. Vaccination certificates won’t be required for eating inside restaurants or for hotel stays, though proof of inoculation will still be needed to attend some larger sports and music events.

Wales sees zero weekly deaths from coronavirus for first time since pandemic began


Wales has reported a week with zero deaths from COVID-19 for the first time since the pandemic began, the Office for National Statistics (ONS) has said.

None of the 573 deaths registered in Wales in the week ending 18 June mentioned COVID-19 on the death certificate, according to the ONS.

The last time this happened was in the week ending 13 March 2020.

Belgium – Number of Covid patients in hospital falls below 500


The number of patients currently in hospital due to coronavirus infections in Belgium has dropped to its lowest point since September last year, according to the latest figures from the Sciensano Public Health Institute published on Sunday morning.

Earlier in May, the Consultative Committee was looking for the number of beds in intensive care occupied by Covid patients to fall below 500, to allow further relaxation of measures to take place. That threshold has now also been passed by hospital cases all together.

Between 10 and 16 June, an average of 542.3 new coronavirus infections were detected per day, down by 45% compared to the previous week. This number this week dropped below 700 for the first time in months, and keep on falling.

Meanwhile, the daily average of testing over the past week decreased by 7% (an average of 38,792.4 tests were carried out) with a positivity rate of 1.9% (down by 1%).

Belgium – Coronavirus cases down by 40% last week


Between 4 and 10 June, an average of 882 new coronavirus infections were detected per day, down 40% from the previous week, according to the latest figures published Monday morning by the Sciensano public health institute.

An average of 40,900 tests have also been carried out daily, with a positivity rate of 2.7%.

Hospitalisations for coronavirus sit at 702 people, with 274 of those patients being treated in intensive care.

The average number of hospital admissions per day due to coronavirus between 7 and 13 June fell to 49.3, a 31% decrease compared to the previous reporting period.

Between 4 and 10 June, an average of 8.6 people died per day as a result of the virus, bringing the total to 25,088 deaths since the start of the pandemic in Belgium.

The incidence, which indicates the average number of new cases per day per 100,000 inhabitants, reached 143.6 over 14 days. The reproduction rate of the virus is still falling and is now 0.76. When it is below 1, this indicator means that the epidemic is tending to slow down.

Global COVID-19 case count down 15% in past week — WHO


Over 3 million novel coronavirus cases and over 73,000 deaths were registered worldwide in the past week, the World Health Organization (WHO) said in a weekly bulletin released in Geneva early on Wednesday.

“Global case and death incidences continued to decrease with over three million new weekly cases and over 73,000 new deaths, a 15% and an 8% decrease respectively, compared to the previous week,” the global organization said in its COVID-19 Weekly Epidemiological Update.

On May 31 – June 6, the global organization was informed about 3,016,005 new cases all over the world, and 73,807 COVID-related deaths. As of June 6, a total of 172,673,097 cases of the infection and 3,718,944 COVID-related fatalities have been reported worldwide.

Last week, case incidence declined in five out of six WHO regions, including Southeast Asia (31%) and Europe (17%). At the same time, Africa reported a 25-percent increase in cases. Mortality increased in the Western Pacific region (up 19%), North and South America (up 4%) and Africa (up 2%), but declined in Europe (down 21%), Southeast Asia (down 21%) and Eastern Mediterranean (down 1%).

The Scottish Government announces no deaths and 695 covid cases in last 24 hours


The Scottish Government has confirmed that no people have died from coronavirus in the last 24 hours with 695 new cases identified overnight.

It means the death toll since last March – of people who first tested positive for the virus within the previous 28 days – remains the same at 7,677.

There are currently 121 people in hospital confirmed to have the virus with 12 being treated in intensive care.

Immunity to the Coronavirus May Persist for Years, Scientists Find


Immunity to the coronavirus lasts at least a year, possibly a lifetime, improving over time especially after vaccination, according to two new studies. The findings may help put to rest lingering fears that protection against the virus will be short-lived.

Together, the studies suggest that most people who have recovered from Covid-19 and who were later immunized will not need boosters. Vaccinated people who were never infected most likely will need the shots, however, as will a minority who were infected but did not produce a robust immune response.

Both reports looked at people who had been exposed to the coronavirus about a year earlier. Cells that retain a memory of the virus persist in the bone marrow and may churn out antibodies whenever needed, according to one of the studies, published on Monday in the journal Nature.